BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10728986)

  • 1. The control of beta-catenin and TCF during embryonic development and cancer.
    Waltzer L; Bienz M
    Cancer Metastasis Rev; 1999; 18(2):231-46. PubMed ID: 10728986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
    Brantjes H; Barker N; van Es J; Clevers H
    Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCF transcription factors: molecular switches in carcinogenesis.
    Roose J; Clevers H
    Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of vegetal cortical dorsal factors in the Xenopus egg with the Wnt/beta-catenin signaling pathway.
    Marikawa Y; Elinson RP
    Mech Dev; 1999 Dec; 89(1-2):93-102. PubMed ID: 10559484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function.
    Townsley FM; Cliffe A; Bienz M
    Nat Cell Biol; 2004 Jul; 6(7):626-33. PubMed ID: 15208637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
    Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
    Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
    Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans.
    Korswagen HC; Coudreuse DY; Betist MC; van de Water S; Zivkovic D; Clevers HC
    Genes Dev; 2002 May; 16(10):1291-302. PubMed ID: 12023307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
    Orme MH; Giannini AL; Vivanco MD; Kypta RM
    Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
    Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
    Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling controls the phosphorylation status of beta-catenin.
    van Noort M; Meeldijk J; van der Zee R; Destree O; Clevers H
    J Biol Chem; 2002 May; 277(20):17901-5. PubMed ID: 11834740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
    Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
    Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.